Related Experiment Video

Updated: May 4, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

13.9K

A novel bullet hits the proteasome

Alexei F Kisselev1

  • 1Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Cancer Cell
|December 17, 2013
PubMed

Insights

Researchers developed a novel irreversible inhibitor targeting Rpn13, a protein overexpressed in solid tumors. This inhibitor shows promise for cancer therapy by selectively targeting cancer cells while sparing most normal tissues.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The 26S proteasome is a crucial cellular machine for protein degradation.
  • Rpn13 is a ubiquitin receptor component of the 26S proteasome.
  • Rpn13 is overexpressed in various solid tumors, suggesting its potential role in cancer progression.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting Rpn13 in solid tumors.
  • To develop and characterize an irreversible inhibitor of Rpn13.

Main Methods:

  • Development of a novel irreversible small molecule inhibitor.
  • Biochemical assays to confirm Rpn13 inhibition.
  • Cellular studies to assess the impact on proteasome function and cancer cell viability.
  • Analysis of Rpn13 expression in tumor tissues.

Main Results:

  • An irreversible inhibitor of Rpn13 was successfully synthesized and characterized.
  • The inhibitor demonstrated potent and selective inhibition of Rpn13.
  • Targeting Rpn13 with the inhibitor led to reduced cancer cell viability.
  • Rpn13 was confirmed to be overexpressed in a significant number of solid tumors.

Conclusions:

  • Rpn13 is a promising therapeutic target for solid tumors.
  • Irreversible Rpn13 inhibition represents a potential new strategy for cancer treatment.
  • Further studies are warranted to explore the clinical efficacy of Rpn13 inhibitors.

More Related Videos

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

6.1K
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

10.3K

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.8K
The Proteasome02:18

The Proteasome

3.9K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
2.2K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
8.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
9.4K